A recent article in Scientific American highlights the need to reform federal drug policy. In “Turn On, Tune In, Get Better: Psychedelic Drugs Hold Medical Promise,” writer Roni Jacobson describes how the FDA and DEA created a Catch-22 situation for scientists who study psychedelics. The federal agencies claim that there is insufficient research to justify removing psychedelics from Schedule I, the most restrictive category of illegal drugs. This legal barrier makes it very difficult for scientists to conduct the necessary research. Even so, the article notes that “Psychedelic drugs are poised to be the next major breakthrough in mental health care.”

Turn On, Tune In, Get Better: Psychedelic Drugs Hold Medical Promise | Scientific American